诺辉健康“造假”内幕：找环卫工人买粪便，一份样本多次检测

Core Viewpoint - The article discusses the fraudulent practices of Nohow Health, revealing how the company manipulated sales data and engaged in deceptive practices that led to its financial downfall and impending liquidation [4][5][6]. Group 1: Fraudulent Practices - Nohow Health was found to have fabricated sales performance, employing methods such as purchasing fecal samples from sanitation workers and splitting samples among fake testing accounts [5]. - The company's top executives were aware of and led the fraudulent activities, with only a few high-ranking officials allowed to attend the most confidential sales strategy meetings [5]. - After initially managing the crisis through public relations, Nohow Health attempted to falsify its annual financial report in early 2024, which resulted in Deloitte's withdrawal from auditing the company [5][6]. Group 2: Sales Strategy and Growth - In 2022, Nohow Health's sales team reported a staggering 260% revenue growth, increasing sales from 200 million to 760 million yuan, despite adverse conditions like the pandemic [10]. - The sales strategy involved creating fictitious sales transactions through third-party platforms, allowing the company to report inflated sales figures [10][12]. - The sales team expanded from about 100 to nearly 500 members in 2022, leading to a shift in tactics from using personal bank cards for transactions to utilizing third-party platforms for larger-scale fraud [12]. Group 3: Consequences and Market Reaction - Following the release of a short-selling report, Nohow Health's stock price plummeted from a peak of 38.95 HKD to 15.7 HKD, with trading volume surging to over 28 million shares in a single day [17][18]. - The company is now facing liquidation, with the board of directors losing decision-making power, and a court hearing scheduled for November 14, 2023 [20]. - Over 4,000 individual investors have registered for compensation claims, with total investments exceeding 700 million yuan, highlighting the widespread financial impact of the company's collapse [20].